000 04031nam a22004334u 4500
001 10.1002/9783527830497
003 Wiley
005 20251030120309.0
007 cr nn 008mam|a
008 231020t2024||||xxu fs| |0|| 0|eng||
020 _a9783527830497
_qelectronic
024 7 _a10.1002/9783527830497
_2doi
041 _aeng
245 0 0 _aOpen Access Databases and Datasets for Drug Discovery
_h[electronic resource]
_cEdited by Antoine Daina, Michael Przewosny, Vincent Zoete.
250 _a1
260 _bWiley
_c2024
264 1 _bWiley
_c2024
300 _a352pp.;
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_2rdaft
347 _bPDF
490 1 _aMethods and Principles in Medicinal Chemistry
520 _aOpen Access Databases and Datasets for Drug Discovery Timely resource discussing the future of data-driven drug discovery and the growing number of open-source databases With an overview of 90 freely accessible databases and datasets on all aspects of drug design, development, and discovery, Open Access Databases and Datasets for Drug Discovery is a comprehensive guide to the vast amount of "free data" available to today's pharmaceutical researchers. The applicability of open-source data for drug discovery and development is analyzed, and their usefulness in comparison with commercially available tools is evaluated. The most relevant databases for small molecules, drugs and druglike substances, ligand design, protein 3D structures (both experimental and calculated), and human drug targets are described in depth, including practical examples of how to access and work with the data. The first part is focused on databases for small molecules, followed by databases for macromolecular targets and diseases. The final part shows how to integrate various open-source tools into the academic and industrial drug discovery and development process. Contributed to and edited by experts with long-time experience in the field, Open Access Databases and Datasets for Drug Discovery includes information on: An extensive listing of open access databases and datasets for computer-aided drug design PubChem as a chemical database for drug discovery, DrugBank Online, and bioisosteric replacement for drug discovery supported by the SwissBioisostere database The Protein Data Bank (PDB) and macromolecular structure data supporting computer-aided drug design, and the SWISS-MODEL repository of 3D protein structures and models PDB-REDO in computational aided drug design (CADD), and using Pharos/TCRD for discovering druggable targets Unmatched in scope and thoroughly reviewing small and large open data sources relevant for rational drug design, Open Access Databases and Datasets for Drug Discovery is an essential reference for medicinal and pharmaceutical chemists, and any scientists involved in the drug discovery and drug development.
650 4 _aDrug Discovery & Development
_991621
650 4 _aComputational Chemistry & Molecular Modeling
_991622
650 4 _aStructural Biology
_976110
653 0 0 _asmall molecules; drugs; druglike substances; ligand design; protein 3D structures; human drug targets; Molecular Modelling Group; pubchem; drugbank online; SwissBioisostere database; The Protein Data Bank; drug design; drug develop; drug data
700 1 _aDaina, Antoine
_4edt
_991623
700 1 _aPrzewosny, Michael
_4edt
_991624
700 1 _aZoete, Vincent
_4edt
_991625
776 0 8 _iPrinted edition:
_z9783527348398
830 0 _aMethods and Principles in Medicinal Chemistry
_991626
856 4 0 _uhttps://doi.org/10.1002/9783527830497
_aWiley Online Library
856 4 0 _uhttps://onlinelibrary.wiley.com/action/showBook?doi=10.1002%2F9783527830497
_aWiley Online Library
856 4 2 _3Cover Image
_uhttps://onlinelibrary.wiley.com/cms/asset/b8f3bc15-00ba-496a-ad96-991c3788b58e/9783527830497.cover.gif
_aWiley Online Library
999 _c67019
_d67019